Steve Schonfeld’s DermTech, Inc. Common Stock DMTK Stock Holding History

Steve Schonfeld’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-21,600	Closed	-$38.2K	–	2800
2022 Q4	$38.2K	Buy	+21,600	New	+$57.5K	﹤0.01%	2280
2022 Q3	–	Sell	-16,572	Closed	-$92K	–	3241
2022 Q2	$92K	Buy	+16,572	New	+$136K	﹤0.01%	2161

Other funds holding DMTK

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

EPIQ Partners Minneapolis, Minnesota $236M AUM 15.39% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Steve Schonfeld's DMTK Position: Q1 2023 in Review

Steve Schonfeld sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2023, closing a stake of 21,600 shares — an estimated $38.2K sold.

Steve Schonfeld first reported a position in DMTK in Q2 2022 and held it in 2 quarters. The position peaked at $92K in Q2 2022. 99 funds tracked by Wall St. Rank hold DMTK as of Q1 2023.

Steve Schonfeld reported no remaining DermTech, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Steve Schonfeld sold 21,600 DermTech, Inc. Common Stock shares in Q1 2023, an estimated $38.2K.
Steve Schonfeld first reported a position in DermTech, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
Steve Schonfeld's DermTech, Inc. Common Stock position peaked at $92K in Q2 2022.
99 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.